MAPLIGHT THERAPEUTICS Trademark

Trademark Overview


On Wednesday, May 18, 2022, a trademark application was filed for MAPLIGHT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MAPLIGHT THERAPEUTICS trademark a serial number of 97417588. The federal status of this trademark filing is REGISTERED as of Tuesday, October 3, 2023. This trademark is owned by MapLight Therapeutics, Inc.. The MAPLIGHT THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of central nervous system disorders; Pharmaceutical preparations for the treatment of central nervous system disorders

Research, drug discovery, and development services in the field of therapeutics for the treatment of central nervous system disorders; Research and development in the field of biopharmaceuticals; Providing medical and scientific research information in the field of biopharmaceuticals
maplight therapeutics

General Information


Serial Number97417588
Word MarkMAPLIGHT THERAPEUTICS
Filing DateWednesday, May 18, 2022
Status700 - REGISTERED
Status DateTuesday, October 3, 2023
Registration Number7179599
Registration DateTuesday, October 3, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of central nervous system disorders; Pharmaceutical preparations for the treatment of central nervous system disorders
Pseudo MarkMAP LIGHT THERAPEUTICS
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch, drug discovery, and development services in the field of therapeutics for the treatment of central nervous system disorders; Research and development in the field of biopharmaceuticals; Providing medical and scientific research information in the field of biopharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 24, 2022
Primary Code005
First Use Anywhere DateThursday, September 30, 2021
First Use In Commerce DateThursday, September 30, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 24, 2022
Primary Code042
First Use Anywhere DateWednesday, June 30, 2021
First Use In Commerce DateWednesday, June 30, 2021

Trademark Owner History


Party NameMapLight Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Party NameMapLight Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Party NameMapLight Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events


Event DateEvent Description
Tuesday, October 3, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 3, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, March 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 7, 2023ASSIGNED TO EXAMINER
Tuesday, May 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 21, 2022NEW APPLICATION ENTERED